Preclinical and Translational Studies in Small Ruminants (Sheep and Goat) as Models for Osteoporosis Research
- 248 Downloads
Purpose of the Review
This review summarizes research on the use of sheep and goats as large animal models of human osteoporosis for preclinical and translational studies.
The most frequent osteoporotic sheep model used is the ovariectomized sheep with 12 months post-operatively or more and the combined treatment of ovariectomized sheep associated to calcium/vitamin D-deficient diet and glucocorticoid applications for 6 months, but other methods are also described, like pinealectomy or hypothalamic-pituitary disconnection in ovariectomized sheep. The goat model for osteoporosis research has been used in a very limited number of studies in osteoporosis research relative to sheep. These osteoporotic small ruminant models are applied for biomaterial research, bone augmentation, efficacy of implant fixation, fragility fracture-healing process improvement, or bone-defect repair studies in the osteopenic or osteoporotic bone.
Sheep are a recognized large animal model for preclinical and translational studies in osteoporosis research and the goat to a lesser extent. Recently, the pathophysiological mechanism underlying induction of osteoporosis in glucocorticoid-treated ovariectomized aged sheep was clarified, being similar to what occurs in postmenopausal women with glucocorticoid-induced osteoporosis. It was also concluded that the receptor activator of NF-κB ligand was stimulated in the late progressive phase of the osteoporosis induced by steroids in sheep. The knowledge of the pathophysiological mechanisms at the cellular and molecular levels of the induction of osteoporosis in small ruminants, if identical to humans, will allow in the future, the use of these animal models with greater confidence in the preclinical and translational studies for osteoporosis research.
KeywordsBone Goat Large animal models Orthopedics Osteoporosis Sheep
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest. José A. Camassa reports and acknowledges the National Council for Scientific and Technological Development (CNPq-Brazil) for his PhD scholarship 202248/2015-1.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95.Google Scholar
- 6.Turner AS. How to select your animal model for osteoporosis research. In: Duque G, Watanabe K, editors. Osteoporosis research—animal models. London, UK: Springer-Verlag; 2011. p. 1–12.Google Scholar
- 9.Smith SY, Varela A, Jolette J. Nonhuman primate models of osteoporosis. In: Duque G, Watanabe K, editors. Osteoporosis research—animal models. London: Springer-Verlag; 2011. p. 135–57.Google Scholar
- 22.• Reinwald S, Burr DB. Other large animal models. In: Duque G, Watanabe K, editors. Osteoporosis research—animal models. London, UK: Springer-Verlag; 2011. p. 159–74. This is an excellent and marvellous review that covers the relevance of the other large animal models, with the exception of the non-human primates, also reporting to the animal and veterinary sciences aspects of the use of these animals as experimental models for osteoporosis research (rabbits, dogs, sheep, goats, and pigs).Google Scholar
- 24.• Oheim R, Amling M, Ignatius A, Pogoda P. Large animal model for osteoporosis in humans: the ewe. Eur Cell Mater. 2012;24:372–85. This is an updated and an in-depth review that covers the relevance of the ewe as a large animal model for osteoporosis study and as a preclinical model for orthopaedic implant and biomaterial research CrossRefPubMedGoogle Scholar
- 25.• Zhang Z, Ren H, Shen G, Qiu T, Liang, Yang Z, et al. Animal models for glucocorticoid-induced postmenopausal osteoporosis: an updated review. Biomed Pharmacother. 2016;84:438–46. This is an updated and an in-depth review that covers the relevance of the creation of animal models (rat, rabbit, sheep) for glucocorticoid-induced postmenopausal osteoporosis and the underlying mechanism of osteoporosis induced by glucocorticoids in OVX animals CrossRefPubMedGoogle Scholar
- 32.Lans C, Khan TE, Curran MM, McCorkle CM. Plant chemistry in veterinary medicine: medicinal constituents and their mechanisms of action. In: Wynn SG, Fougere B, editors. Veterinary herbal medicine. St. Louis, Missouri: Elsevier Health Sciences, Mosby; 2007. p. 159–82.Google Scholar
- 37.• Egermann M, Goldhahn J, Holz R, Schneider E, Lill CA. A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare. Lab Anim. 2008;42:453–64. This is a study that reports to the benefits and complications of the induction methods to obtain osteoporosis in sheep, namely about the combined treatment of ovariectomy, calcium/vitamin D-restricted diet and glucocorticoids as one of the most effective in view of the induction of severe osteoporosis in sheep CrossRefPubMedGoogle Scholar
- 40.Veigel E, Moore RJ, Zarrinkalam MR, Schulze D, Sauerbier S, Schmelzeisen R, et al. Osteopenia in the maxillofacial area: a study in sheep. Osteoporos Int. 2011;22:1115–21.Google Scholar
- 42.Zarrinkalam MR, Schultz CG, Parkinson IH, Moore RJ. Osteoporotic characteristics persist in the spine of ovariectomized sheep after withdrawal of corticosteroid administration. J Osteoporos. 2012;182509Google Scholar
- 44.Kennedy OD, Brennan O, Mahony NJ, Rackard SM, O’Brien FJ, Taylor D, et al. Effects of high bone turnover on the biomechanical properties of the L3 vertebra in an ovine model of early stage osteoporosis. Spine. 2008;33:2518–23.Google Scholar
- 45.Kennedy OD, Brennan O, Mahony NJ, Rackard SM, O’Brien FJ, Taylor D, et al. The behaviour of fatigue-induced microdamage in compact bone samples from control and ovariectomised sheep. Stud Health Technol Inform. 2008;133:148–55.Google Scholar
- 47.Kennedy OD, Brennan O, Rackard SM, Staines A, O’Brien FJ, Taylor D, et al. Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res. 2009;27:303–9.Google Scholar
- 55.Oheim R, Beil FT, Barvencik F, Egermann M, Amling M, Clarke IJ, et al. Targeting the lateral but not the third ventricle induces bone loss in ewe: an experimental approach to generate an improved large animal model of osteoporosis. J Trauma Acute Care Surg. 2012;72:720–6.Google Scholar
- 57.MacLeay JM, Olson JD, Enns RM, Les CM, Toth CA, Wheeler DL, et al. Dietary-induced metabolic acidosis decreases bone mineral density in mature ovariectomized ewes. Calcif Tissue Int. 2004;75:431–7.Google Scholar
- 61.Jainudeen MR, Wahid H, Hafez ESE. Sheep and goats. In: Hafez B, Hafez ESE, editors. Reproduction in farm animals. 7th ed. Baltimore: Lippincott Williams & Wilkins; 2000. p. 172–81.Google Scholar
- 66.Brennan O, Kuliwaba JS, Lee TC, Parkinson IH, Fazzalari NL, McNamara LM, et al. Temporal changes in bone composition, architecture, and strength following estrogen deficiency in osteoporosis. Calcif Tissue Int. 2012;91:440–9.Google Scholar
- 67.Leung KS, Siu WS, Cheung NM, Lui PY, Chow DH, James A, et al. Goats as an osteopenic animal model. J Bone Miner Res. 2001;16:2348–55.Google Scholar
- 70.Yu Z, Wang G, Tang T, Fu L, Yu X, Zhu Z, et al. Long-term effects of ovariectomy on the properties of bone in goats. Exp Ther Med. 2015;9:1967–73.Google Scholar
- 72.Goldhahn J, Neuhoff D, Schaeren S, Steiner B, Linke B, Aebi M, et al. Osseointegration of hollow cylinder based spinal implants in normal and osteoporotic vertebrae: a sheep study. Arch Orthop Trauma Surg. 2006;126:554–61.Google Scholar
- 74.Galovich LA, Perez-Higueras A, Altonaga JR, Orden JM, Barba ML, Morillo MT. Biomechanical, histological and histomorphometric analyses of calcium phosphate cement compared to PMMA for vertebral augmentation in a validated animal model. Eur Spine J. 2011;20:376–82.CrossRefPubMedPubMedCentralGoogle Scholar
- 75.Fini M, Pierini G, Giavaresi G, Biagini G, Mattioli Belmonte MM, Nicoli Aldini N, et al. The ovariectomised sheep as a model for testing biomaterials and prosthetic devices in osteopenic bone: a preliminary study on iliac crest biopsies. Int J Artif Organs. 2000;23:275–81.CrossRefPubMedGoogle Scholar
- 78.Fini M, Giavaresi G, Greggi T, Martini L, Aldini NN, Parisini P, et al. Biological assessment of the bone-screw interface after insertion of uncoated and hydroxyapatite-coated pedicular screws in the osteopenic sheep. J Biomed Mater Res A. 2003;66:176–83.Google Scholar
- 81.Egermann M, Baltzer AW, Adamaszek S, Evans C, Robbins P, Schneider E, et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther. 2006;17:507–17.Google Scholar
- 82.Phillips FM, Turner AS, Seim HB 3rd, MacLeay J, Toth CA, Pierce AR, et al. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J. 2006;6:500–6.Google Scholar
- 83.Borsari V, Fini M, Giavaresi G, Rimondini L, Chiesa R, Chiusoli L, et al. Sandblasted titanium osteointegration in young, aged and ovariectomized sheep. Int J Artif Organs. 2007;30:163–72.Google Scholar
- 84.Borsari V, Fini M, Giavaresi G, Rimondini L, Consolo U, Chiusoli L, et al. Osteointegration of titanium and hydroxyapatite rough surfaces in healthy and compromised cortical and trabecular bone: in vivo comparative study on young, aged, and estrogen-deficient sheep. J Orthop Res. 2007;25:1250–60.CrossRefPubMedGoogle Scholar
- 85.Stadelmann VA, Gauthier O, Terrier A, Bouler JM, Pioletti DP. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study. Eur Cell Mater. 2008;16:10–6.Google Scholar
- 89.Liu D, Lei W, Wu ZX, Gao MX, Wan SY, Fu SC, et al. Augmentation of pedicle screw stability with calcium sulfate cement in osteoporotic sheep: biomechanical and screw-bone interfacial evaluation. J Spinal Disord Tech. 2011;24:235–41.Google Scholar
- 97.Eschler A, Roepenack P, Herlyn PK, Roesner J, Martin H, Vollmar B, et al. Intrabody application of eptotermin alpha enhances bone formation in osteoporotic fractures of the lumbar spine; however, fails to increase biomechanical stability—results of an experimental sheep model. Growth Factors. 2015;33:290–7.CrossRefPubMedGoogle Scholar
- 98.Eschler A, Röpenack P, Herlyn PK, Roesner J, Pille K, Büsing K, et al. The standardized creation of a lumbar spine vertebral compression fracture in a sheep osteoporosis model induced by ovariectomy, corticosteroid therapy and calcium/phosphorus/vitamin D-deficient diet. Injury. 2015;46:S17–23.CrossRefPubMedGoogle Scholar
- 99.Eschler A, Roepenack P, Roesner J, Herlyn PK, Martin H, Reichel M, et al. Cementless titanium mesh fixation of osteoporotic burst fractures of the lumbar spine leads to bony healing: results of an experimental sheep model. Biomed Res Int. 2016;4094161Google Scholar
- 102.Andreasen CM, Ding M, Andersen TL, Overgaard S. Effects of substitute coated with hyaluronic acid or poly-lactic acid on implant fixation: experimental study in ovariectomized and glucocorticoid-treated sheep. J Tissue Eng Regen Med. 2017; https://doi.org/10.1002/term.2447.
- 105.Gunnella F, Kunisch E, Maenz S, Horbert V, Xin L, Mika J, et al. The GDF5 mutant BB-1 enhances the bone formation induced by an injectable, poly(l-lactide-co-glycolide) acid (PLGA) fiber-reinforced, brushite-forming cement in a sheep defect model of lumbar osteopenia. Spine J. 2017; https://doi.org/10.1016/j.spinee.2017.10.002.
- 109.Chavassieux P, Garnero P, Duboeuf F, Vergnaud P, Brunner-Ferber F, Delmas PD, et al. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study. J Bone Miner Res. 2001;16:89–96.Google Scholar
- 116.Leung KS, Siu WS, Li SF, Qin L, Cheung WH, Tam KF, et al. An in vitro optimized injectable calcium phosphate cement for augmenting screw fixation in osteopenic goats. J Biomed Mater Res B Appl Biomater. 2006;78:153–60.Google Scholar
- 120.•• Andreasen CM, Ding M, Overgaard S, Bollen P, Andersen TL. A reversal phase arrest uncoupling the bone formation and resorption contributes to the bone loss in glucocorticoid treated ovariectomised aged sheep. Bone. 2015;75:32–9. This a study showing that glucocorticoid treatment of OVX sheep induces a significant bone loss, promoted by an arrest of the reversal phase, resulting in an uncoupling of the bone formation and resorption during the reversal phase, like in postmenopausal women with glucocorticoid-induced osteoporosis, supporting the importance of this large animal model for the study of the pathophysiology of this disorder and as a preclinical model for orthopedic implant and biomaterial research CrossRefPubMedGoogle Scholar
- 121.Jensen PR, Andersen TL, Abdallah BM, Hauge E, Bollerslev J, Delaisse JM. Arrest of the reversal phase in postmenopausal and glucocorticoid-induced osteoporosis. J Bone Miner Res. 2011;26:S57.Google Scholar